U.S. GAO:
Figure 1: Growth in Sales of Memory Supplements and Dietary Supplements, 2006 through 2015
U.S. GAO:
Figure 5: Decrease in FDA First Cycle Review Time for Abbreviated New Drug Applications, Fiscal Years 2013 through 2015
U.S. GAO:
Figure 6: Decrease in FDA First Cycle Review Time for Prior Approval Supplements, Fiscal Years 2013 through 2015
U.S. GAO:
Figure 2: Board of Veterans' Appeals Decision Times, from the Board's Receipt of the Certified Appeal to Its Decision, Fiscal Years 2011-2015
U.S. GAO:
Figure 1: Growth in OSHA's Outreach Training Program - Number of Workers Trained From Fiscal Year 2000 to 2016
U.S. GAO:
Figure 1: Possible Ways That Health Information Can Be Exchanged with a Post-Acute Care Provider
U.S. GAO:
Figure 1: States with Current or Planned Managed Long-Term Services and Supports (MLTSS) Programs, October 2016
U.S. GAO:
Figure 2: Examples of Examination Rooms For Women Veterans at Department of Veterans Affairs Medical Centers (VAMC)
U.S. GAO:
Figure 1: Centers for Disease Control and Prevention (CDC) Reported Spending on EARLY Act Activities, Fiscal Years 2010 through 2016
U.S. GAO:
Figure 3: Percentage Change from 2012 to 2014 in Number of Beneficiaries Receiving Competitive Bidding Program (CBP) Round 2 Durable Medical Equipment (DME) Items and in Number of Items Received
U.S. GAO:
Figure 1: A General Overview of How to Calculate Physician Performance on Measure of Blood Pressure Control
U.S. GAO:
Figure 1: National Institutes of Health-Funded Grants and Cooperative Agreements (Research Projects), Direct Costs, and Indirect Costs by Organization Type in Fiscal Year 2015
U.S. GAO:
Figure 1: Number of Reported Hacking and Information Technology Breaches Affecting Health Care Records of 500 Individuals or More
U.S. GAO:
Figure 4: Sites around the World that Received Viable Bacillus anthracis (anthrax) Samples from 2004 through 2015 Thought to be Inactivated from the Department of Defense's Dugway Proving Ground
U.S. GAO:
Figure 1: Summary of GAO's Fictitious Applications for 2016 Open-Enrollment Testing for PPACA Coverage through the Marketplaces
U.S. GAO:
Figure 1: Key Interactions and Stakeholders Involved in the Distribution of and Payment for Generic Drugs
U.S. GAO:
Figure 2: Price Trends under Medicare Part D for the Changing Basket and Established Basket of Generic Drugs, First Quarter 2010 through the Second Quarter 2015
U.S. GAO:
Figure 1: Use of Another Planned Permanent Living Arrangement (APPLA) Case Goal for Indian and Non-Indian Children in Foster Care, as of September 30, 2014
U.S. GAO:
Figure 1: The Number of States Where the Market Share of the Three Largest Issuers Was at Least 80 Percent, by Market, 2011-2014
U.S. GAO:
Figure 1: Medicare Expenditures on and Administrations of Part B Drugs, by Payment Methodology (2014)
